Quel est le prix pour Aeolus Pharmaceuticals, Inc. (AOLS)

Le prix pour Aeolus Pharmaceuticals, Inc. (AOLS) est $0.0001

Quelle est la capitalisation boursière pour Aeolus Pharmaceuticals, Inc. (AOLS)

La capitalisation boursière pour Aeolus Pharmaceuticals, Inc. (AOLS) est $15.21K

Aeolus Pharmaceuticals, Inc. (AOLS) Dividendes

Aeolus Pharmaceuticals, Inc. is a biopharmaceutical firm specializing in the development of innovative therapeutic compounds. Operating within the United States, the company's research pipeline addresses a diverse range of critical medical challenges, including biodefense, fibrotic conditions, oncology, infectious diseases, and central nervous system disorders. A core focus involves a distinct class of catalytic antioxidant compounds, which are being advanced as essential medical countermeasures against threats from nuclear, radiological, and chemical weapons, in addition to therapies for respiratory, neurological, and oncological ailments. Their flagship product candidate, AEOL 10150, has successfully navigated two Phase I clinical trials. This compound is being developed to combat the pulmonary complications associated with acute radiation syndrome, and also serves as a crucial protective agent against exposure to chemical vesicants and nerve agents. Further expanding its pipeline, Aeolus is also pursuing AEOL 11114B, AEOL 11203, and AEOL 11207 for the treatment of Parkinson's disease, alongside AEOL 20415, designed to address various infectious diseases. Established in 1994, Aeolus Pharmaceuticals is headquartered in Mission Viejo, California.

Année	Dividende (ajusté pour divisions d’actions)	Changez
Pas assez de données pour les dates fournies.

Année

Dividende (ajusté pour divisions d’actions)

Changez

Pas assez de données pour les dates fournies.

Année	Dividende	Changez
Pas assez de données pour les dates fournies.

Année

Dividende

Changez

Pas assez de données pour les dates fournies.

Entreprise	Nombre de paiements de dividendes	Pays
MERCK Kommanditgesellschaft auf Aktien MER.SW	0.00%	DE
Merck KGaA MRK.DE	0.00%	DE
Takeda Pharmaceutical Company Limited 4502.T	0.00%	JP
Galderma Group AG GALD.SW	0.00%	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	38.00%	IN

Entreprise

Nombre de paiements de dividendes

Pays